New Deal Advisors supports Naxicap Partners in the acquisition of Alchimia
Milan, 21 October 2022 – New Deal Advisors, an independent company specialising in advisory services to M&A Transactions, has supported Moria SA, a portfolio company of Naxicap Partners, in the acquisition of Alchimia Srl.
Moria SA, active in the field of the ophthalmic microsurgery, refractive surgery and transplant surgery of ophthalmic products, completes the acquisition of Alchimia Srl, a manufacturer of medical devices for ophthalmic surgery and human tissue banks.
New Deal Advisors, with a team led by Guido Pelissero (Partner) has provided Financial Due Diligence Services to Moria SA, a portfolio company of the French private equity fund Naxicap Partners.
New Deal Advisors is an independent firm specialising in advisory services in the M&A field. Established in 2012, New Deal Advisors provides support in a broad variety of extraordinary transactions streams including mergers and acquisitions, restructuring, transformation processes, forensic and litigation activities, fairness opinions and valuation services. New Deal Advisors has worked for more than a decade alongside private equity funds, investment holdings, family offices, financial institutions and strategic players achieving to date the finalisation of over 200 deals.